Source: Annual Congress 2002 - COPD - general -3
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. E. Makarevich (Minsk, Belarus). The relationship of alpha1-antitripsin level with the dynamics of free and peptide-binded oxyproline in COPD progression. Eur Respir J 2002; 20: Suppl. 38, 1670

Member's Comments

No comment yet.

Related content which might interest you: The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 The relationship between the serum YKL-40 level and severity of asthma Source: Annual Congress 2012 - Asthma management Year: 2012 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 Assessment of plasma klotho concentration in stable COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 Is there a relationship between severity of COPD and C-reactive protein (CRP) levels? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Changes in urinary biomarkers between stable state and exacerbation of COPD Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Serum levels of hyaluronic acid are associated with COPD severity and predict survival Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018 Year: 2019 Beclin1 circulating levels and accelerated ageing markers in COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Low income and progression free survival in idiopathic pulmonary fibrosis: an association to  uncover Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Association of airway bacterial load with serum CRP and fibrinogen in stable COPD Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006 Could KL-6 levels in COVID-19 help to predict lung disease ? Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017